Stockholders’ Equity (Tables)
|
12 Months Ended |
Feb. 28, 2026 |
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
| Schedule of Stock Option Activity |
Option
activity for the year ended February 28, 2026 was as follows:
Schedule of Stock Option Activity
| | |
| | |
Weighted Average | | |
Weighted Average | | |
| |
| | |
| | |
Exercise | | |
Remaining | | |
Aggregate | |
| | |
| | |
Price | | |
Contractual | | |
Intrinsic | |
| | |
Options | | |
($) | | |
Life (Yrs.) | | |
Value ($) | |
| Options outstanding at February 28, 2025 | |
| 76,342 | | |
| 52.69 | | |
| 1.60 | | |
| - | |
| Granted | |
| 914,825 | | |
| 4.39 | | |
| 2.28 | | |
| | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| (76,342 | ) | |
| 52.69 | | |
| - | | |
| - | |
| Options outstanding at February 28, 2026 | |
| 914,825 | | |
| 4.39 | | |
| 2.28 | | |
| - | |
| Options expected to vest in the future as of February 28, 2026 | |
| - | | |
| - | | |
| - | | |
| - | |
| Options exercisable at February 28, 2026 | |
| 914,825 | | |
| 4.39 | | |
| 2.28 | | |
| - | |
| Options vested, exercisable, and options expected to vest at February 28, 2026 | |
| 914,825 | | |
| 4.39 | | |
| 2.28 | | |
| - | |
|
| Schedule of Warranty Activity |
Warrant
activity for the year ended February 28, 2026 was as follows:
Schedule of Warranty Activity
| | |
| | |
Weighted Average | | |
Weighted Average | |
| | |
| | |
Exercise | | |
Remaining | |
| | |
| | |
Price | | |
Contractual | |
| | |
Warrants | | |
($) | | |
Life (Yrs.) | |
| Warrants outstanding at February 28, 2025 | |
| 3,015,885 | | |
| 5.36 | | |
| 3.84 | |
| Granted | |
| 1,998,104 | | |
| 3.34 | | |
| 3.96 | |
| Exercised | |
| (237,429 | ) | |
| 3.02 | | |
| - | |
| Forfeited or cancelled | |
| (17,979 | ) | |
| 128.32 | | |
| - | |
| Warrants outstanding at February 28, 2026 | |
| 4,758,581 | | |
| 4.15 | | |
| 3.48 | |
|
| Warrant [Member] |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
The
fair value of warrants issued during the year was estimated using the Black-Scholes model with the following assumptions for the twelve
months ended February 28, 2026:
Assumptions:
Schedule of Share Based Payments Award Stock Options Valuation Assumptions
| | |
2026 | |
| Dividend yield | |
| 0.00 | % |
| Risk-free interest rate | |
| 3.49
%- 4.14 | % |
| Expected volatility | |
| 118.8%- 161.0 | % |
| Expected life (in years) | |
| 1.50-5.03 | |
|
| Share-Based Payment Arrangement, Option [Member] |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
| Schedule of Share Based Payments Award Stock Options Valuation Assumptions |
The
fair value of outstanding option awards was estimated using the Black-Scholes model with the following assumptions for the twelve months
ended February 28, 2026:
Assumptions:
Schedule of Share Based Payments Award Stock Options Valuation Assumptions
| | |
2026 | |
| Dividend yield | |
| 0.0 | % |
| Risk-free interest rate | |
| 3.56%-4.08 | % |
| Expected volatility | |
| 122.0%-140 | % |
| Expected life (in years) | |
| 1.0-5.0 | |
|
| Stock Appreciation Rights [Member] |
|
| Accumulated Other Comprehensive Income (Loss) [Line Items] |
|
| Schedule of Stock Option Activity |
SARs
activity for the year ended February 28, 2026 was as follows:
Schedule of Stock Option Activity
| | |
| | |
Weighted Average | | |
Weighted Average | | |
| |
| | |
| | |
Exercise | | |
Remaining | | |
Aggregate | |
| | |
| | |
Price | | |
Contractual | | |
Intrinsic | |
| | |
SARs | | |
($) | | |
Life (Yrs.) | | |
Value ($) | |
| SARs outstanding at February 28, 2025 | |
| 40,223 | | |
| 44.80 | | |
| 1.99 | | |
| - | |
| Exercised | |
| - | | |
| - | | |
| - | | |
| - | |
| Forfeited or cancelled | |
| (3,907 | ) | |
| 52.60 | | |
| - | | |
| - | |
| SARs outstanding at February 28, 2026 | |
| 36,316 | | |
| 43.96 | | |
| 1.17 | | |
| - | |
| SARs expected to vest in the future as of February 28, 2026 | |
| - | | |
| - | | |
| - | | |
| - | |
| SARs exercisable at February 28, 2026 | |
| 36,316 | | |
| 43.96 | | |
| 1.17 | | |
| - | |
| SARs vested, exercisable, and SARs expected to vest at February 28, 2026 | |
| 36,316 | | |
| 43.96 | | |
| 1.17 | | |
| - | |
|